Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

MedicaMetrix Signs Letter of Intent to Use Vytex® Natural Rubber Latex as Material of Choice in ProstaGlove™

April 19, 2011 By Bio-Medicine.Org

ATLANTA, April 19, 2011 /PRNewswire/ — Vystar® Corporation
(OTCBB: VYST), the creator of Vytex® Natural Rubber Latex
(NRL), a multi-patented, all-natural raw material that contains
significantly reduced levels of the antigenic proteins found in
natural rubber latex, announces that urological medical device
manufacturer MedicaMetrix, Inc. has signed a Letter of Intent to
use Vytex NRL as the material of choice in its ProstaGlove™, a
diagnostic device currently in clinical trial development for the
quantitative, physician office-based measurement of prostate
cancer.

(Logo: http://photos.prnewswire.com/prnh/20100203/CL48049LOGO
 )

ProstaGlove, while still in development, is being designed to
improve the diagnosis of prostate cancer by enabling the use of PSA
density (PSAD) as a screen, in conjunction with PSA, to reduce
unnecessary prostate biopsies with a proposed future net savings in
prostate cancer diagnosis (after ProstaGlove sales), currently
forecasted at more than $400 million in the US and $1 Billion
globally.  ProstaGlove, when approved for use and sale,
expects to enable the low-cost determination of prostate volume and
PSAD, which could potentially eliminate hundreds of thousands of
biopsies and could save hundreds of millions of dollars annually in
the US in the cost of diagnosing prostate cancer.

Christopher G. LaFarge, Chief Executive Officer of MedicaMetrix,
said, “MedicaMetrix has developed a system for the quantitative
measurement of prostate volume that we believe will become the new
‘gold standard’ for prostate exams.  ProstaGlove will allow
measurement of prostate volume and determination of PSAD to
identify patients with elevated PSA appropriate for prostate
biopsy. We believe that the physical characteristics of Vytex NRL,
including its durability and tactile sensitivity, lend it the
potential to be a superior choice of material for our product

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 13, 2022
Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech